Microarray analysis reveals increased expression of Δnp63α in seborrhoeic keratosis

British Journal of Dermatology

Volumn 166, Issue 2, 2012, Pages 337-342

  Seo, E Y ^a,b   Lee, D H ^a,b   Lee, Y ^a,b   Cho, K H ^a,b   Eun, H C ^a,b   Chung, J H ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA NP63 ALPHA PROTEIN; PROTEIN; PROTEIN P63; SMALL INTERFERING RNA; TENSIN; TNS4 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CASE REPORT; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; MICROARRAY ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEBORRHEIC KERATOSIS; SKIN DEFECT;

AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; KERATOSIS, SEBORRHEIC; MALE; MICROARRAY ANALYSIS; MICROFILAMENT PROTEINS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 84862794766     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10665.x     Document Type: Article

References (38)

1. Hafner C, Vogt T,. Seborrheic keratosis. J Dtsch Dermatol Ges 2008; 6: 664-77.
2. Kwon OS, Hwang EJ, Bae JH, et al. Seborrheic keratosis in the Korean males: causative role of sunlight. Photodermatol Photoimmunol Photomed 2003; 19: 73-80.
3. Yeatman JM, Kilkenny M, Marks R,. The prevalence of seborrhoeic keratoses in an Australian population: does exposure to sunlight play a part in their frequency? Br J Dermatol 1997; 137: 411-14.
4. Nakamura H, Hirota S, Adachi S, et al. Clonal nature of seborrheic keratosis demonstrated by using the polymorphism of the human androgen receptor locus as a marker. J Invest Dermatol 2001; 116: 506-10.
5. Logie A, Dunois-Larde C, Rosty C, et al. Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans. Hum Mol Genet 2005; 14: 1153-60.
6. Mandinova A, Kolev V, Neel V, et al. A positive FGFR3/FOXN1 feedback loop underlies benign skin keratosis versus squamous cell carcinoma formation in humans. J Clin Invest 2009; 119: 3127-37.
7. Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998; 2: 305-16.
8. Guo X, Keyes WM, Papazoglu C, et al. TAp63 induces senescence and suppresses tumorigenesis in vivo. Nat Cell Biol 2009; 11: 1451-7.
9. Keyes WM, Pecoraro M, Aranda V, et al. DeltaNp63alpha is an oncogene that targets chromatin remodeler Lsh to drive skin stem cell proliferation and tumorigenesis. Cell Stem Cell 2011; 8: 164-76.
10. Pepper SD, Saunders EK, Edwards LE, et al. The utility of MAS5 expression summary and detection call algorithms. BMC Bioinformatics 2007; 8: 273.
11. Lopardo T, Lo Iacono N, Marinari B, et al. Claudin-1 is a p63 target gene with a crucial role in epithelial development. PLoS ONE 2008; 3: e2715.
12. Mukhopadhyay A, Deplancke B, Walhout AJ, et al. Chromatin immunoprecipitation (ChIP) coupled to detection by quantitative real-time PCR to study transcription factor binding to DNA in Caenorhabditis elegans. Nat Protoc 2008; 3: 698-709.
13. Herfs M, Hubert P, Suarez-Carmona M, et al. Regulation of p63 isoforms by snail and slug transcription factors in human squamous cell carcinoma. Am J Pathol 2010; 176: 1941-9.
14. Sayan AE, D'Angelo B, Sayan BS, et al. p73 and p63 regulate the expression of fibroblast growth factor receptor 3. Biochem Biophys Res Commun 2010; 394: 824-8.
15. Testoni B, Borrelli S, Tenedini E, et al. Identification of new p63 targets in human keratinocytes. Cell Cycle 2006; 5: 2805-11.
16. Gu X, Coates PJ, Boldrup L, et al. p63 contributes to cell invasion and migration in squamous cell carcinoma of the head and neck. Cancer Lett 2008; 263: 26-34.
17. Ortt K, Sinha S,. Derivation of the consensus DNA-binding sequence for p63 reveals unique requirements that are distinct from p53. FEBS Lett 2006; 580: 4544-50.
18. Hafner C, Toll A, Fernandez-Casado A, et al. Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors. Proc Natl Acad Sci USA 2010; 107: 20780-5.
19. Mills AA, Zheng B, Wang XJ, et al. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999; 398: 708-13.
20. Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999; 398: 714-18.
21. Adorno M, Cordenonsi M, Montagner M, et al. A mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis. Cell 2009; 137: 87-98.
22. Crum CP, McKeon FD,. p63 in epithelial survival, germ cell surveillance, and neoplasia. Annu Rev Pathol 2010; 5: 349-71.
23. Deyoung MP, Ellisen LW,. p63 and p73 in human cancer: defining the network. Oncogene 2007; 26: 5169-83.
24. Muller PA, Caswell PT, Doyle B, et al. Mutant p53 drives invasion by promoting integrin recycling. Cell 2009; 139: 1327-41.
25. Su X, Chakravarti D, Cho MS, et al. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 2010; 467: 986-90.
26. Koster MI, Kim S, Mills AA, et al. p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev 2004; 18: 126-31.
27. Koster MI, Lu SL, White LD, et al. Reactivation of developmentally expressed p63 isoforms predisposes to tumor development and progression. Cancer Res 2006; 66: 3981-6.
28. Candi E, Dinsdale D, Rufini A, et al. TAp63 and DeltaNp63 in cancer and epidermal development. Cell Cycle 2007; 6: 274-85.
29. Carroll DK, Carroll JS, Leong CO, et al. p63 regulates an adhesion programme and cell survival in epithelial cells. Nat Cell Biol 2006; 8: 551-61.
30. Katz M, Amit I, Citri A, et al. A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration. Nat Cell Biol 2007; 9: 961-9.
31. Vogt L, Schrimpf SP, Meskenaite V, et al. Calsyntenin-1, a proteolytically processed postsynaptic membrane protein with a cytoplasmic calcium-binding domain. Mol Cell Neurosci 2001; 17: 151-66.
32. Katze MG, He Y, Gale M Jr,. Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2002; 2: 675-87.
33. Gushi A, Kanekura T, Kanzaki T, et al. Detection and sequences of human papillomavirus DNA in nongenital seborrhoeic keratosis of immunopotent individuals. J Dermatol Sci 2003; 31: 143-9.
34. Li YH, Chen G, Dong XP, et al. Detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in nongenital seborrhoeic keratosis. Br J Dermatol 2004; 151: 1060-5.
35. Alonso L, Fuchs E,. Stem cells in the skin: waste not, Wnt not. Genes Dev 2003; 17: 1189-200.
36. Bittner M, Meltzer P, Chen Y, et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000; 406: 536-40.
37. Reischl J, Schwenke S, Beekman JM, et al. Increased expression of Wnt5a in psoriatic plaques. J Invest Dermatol 2007; 127: 163-9.
38. Balciunaite G, Keller MP, Balciunaite E, et al. Wnt glycoproteins regulate the expression of FoxN1, the gene defective in nude mice. Nat Immunol 2002; 3: 1102-8.